Overall market sentiment has been high on Scpharmaceuticals Inc (SCPH) stock lately. SCPH receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Scpharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SCPH!
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With SCPH Stock Today?
Scpharmaceuticals Inc (SCPH) stock is trading at $6.06 as of 12:24 PM on Thursday, Feb 29, a rise of $0.04, or 0.66% from the previous closing price of $6.02. The stock has traded between $6.02 and $6.28 so far today. Volume today is below average. So far 121,708 shares have traded compared to average volume of 221,826 shares.
To see InvestorsObserver's Sentiment Score for Scpharmaceuticals Inc click here.
More About Scpharmaceuticals Inc
scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
Click Here to get the full Stock Report for Scpharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
